IRIS
CALZETTA, LUIGINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 46.542
AS - Asia 7.655
EU - Europa 4.915
SA - Sud America 1.105
AF - Africa 83
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 13
Totale 60.336
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 46.383
SG - Singapore 3.777
CN - Cina 1.272
BR - Brasile 903
IT - Italia 861
RU - Federazione Russa 835
HK - Hong Kong 808
IE - Irlanda 655
VN - Vietnam 597
KR - Corea 538
UA - Ucraina 513
FR - Francia 461
DE - Germania 440
PL - Polonia 307
GB - Regno Unito 247
FI - Finlandia 230
JP - Giappone 186
SE - Svezia 120
IN - India 103
CA - Canada 88
NL - Olanda 79
ID - Indonesia 71
AR - Argentina 66
ES - Italia 41
BD - Bangladesh 37
MX - Messico 35
IQ - Iraq 34
EC - Ecuador 33
PK - Pakistan 29
ZA - Sudafrica 29
TR - Turchia 28
AT - Austria 26
CO - Colombia 25
BE - Belgio 23
UZ - Uzbekistan 23
VE - Venezuela 21
AU - Australia 18
CL - Cile 18
MY - Malesia 17
PH - Filippine 17
TW - Taiwan 16
PE - Perù 15
EG - Egitto 14
PY - Paraguay 12
IL - Israele 11
JO - Giordania 11
LT - Lituania 11
MA - Marocco 11
SA - Arabia Saudita 11
GR - Grecia 10
TH - Thailandia 10
A2 - ???statistics.table.value.countryCode.A2??? 9
AE - Emirati Arabi Uniti 9
IR - Iran 9
RO - Romania 9
UY - Uruguay 9
CR - Costa Rica 8
PT - Portogallo 8
NP - Nepal 7
PA - Panama 7
HU - Ungheria 6
KZ - Kazakistan 6
TN - Tunisia 6
AL - Albania 5
DZ - Algeria 5
KE - Kenya 5
NZ - Nuova Zelanda 5
AZ - Azerbaigian 4
CH - Svizzera 4
ET - Etiopia 4
EU - Europa 4
JM - Giamaica 4
KH - Cambogia 4
MK - Macedonia 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
SN - Senegal 2
AM - Armenia 1
BS - Bahamas 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
Totale 60.324
Salva come PNG Salva come JPEG
Città #
Wilmington 11.606
Houston 11.248
Woodbridge 10.252
Fairfield 1.944
Singapore 1.690
Ashburn 1.109
Ann Arbor 989
San Jose 819
Seattle 802
Hong Kong 792
Chandler 749
Cambridge 668
Dublin 567
Beijing 427
Medford 422
Jacksonville 351
Dearborn 325
Santa Clara 286
Council Bluffs 285
Kraków 280
The Dalles 246
Rome 233
Los Angeles 212
New York 209
Ho Chi Minh City 205
Lawrence 195
Lauterbourg 172
Tokyo 164
Hanoi 152
Moscow 139
Boardman 136
Colorado Springs 127
Zhengzhou 119
San Diego 115
Helsinki 109
Buffalo 103
São Paulo 98
Dallas 97
Chicago 96
Menlo Park 74
Milan 66
Naples 60
London 49
Monte Vista 47
Norwalk 44
Redondo Beach 43
Jakarta 40
North Bergen 39
Nuremberg 39
Redwood City 39
Shanghai 39
Guangzhou 34
Toronto 30
Frankfurt am Main 29
Orem 29
Phoenix 29
Salt Lake City 29
Rio de Janeiro 28
Nanjing 27
Hangzhou 26
Brooklyn 24
Hefei 24
Mountain View 23
Verona 23
Lappeenranta 22
Palo Alto 22
Belo Horizonte 21
Brussels 20
Haiphong 20
Warsaw 20
Chennai 19
Columbus 19
Tashkent 19
Atlanta 18
Elk Grove Village 18
Munich 18
Da Nang 17
Kunming 17
Mülheim 17
Stockholm 17
Brasília 16
Chengdu 16
Jinan 16
Parma 16
Poplar 16
Saint Petersburg 16
Denver 15
Detroit 15
Montreal 15
Seoul 15
Tampa 15
Baghdad 14
Johannesburg 14
San Francisco 14
Salvador 13
Ankara 12
Charlotte 12
Curitiba 12
Guayaquil 12
Mumbai 12
Totale 50.062
Salva come PNG Salva come JPEG
Nome #
Asthma and COPD in an Italian adult population: Role of BMI considering the smoking habit 507
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis 505
Interaction between corticosteroids and muscarinic antagonists in human airways 503
Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells 503
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD 500
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis 497
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? 488
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond 484
A Novel and Effective Balanced Intravenous-Inhalant Anaesthetic Protocol in Swine by Using Unrestricted Drugs 482
A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD 482
Glucagon-like peptide 1 receptor: A novel pharmacological target for treating human bronchial hyperresponsiveness 481
Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD 479
LABA/LAMA combination in copd: A meta-analysis on the duration of treatment 473
Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation 473
Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside 469
Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells 469
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 466
High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. 463
Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update 461
Optimizing drug delivery in COPD: The role of inhaler devices 460
Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases 460
Occupational allergy to horse allergens: More than exposure to horses! 458
Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis 455
Asthma and comorbid medical illness. 454
Pharmacological treatments in asthma-affected horses: A pair-wise and network meta-analysis 451
Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents? 448
Can pet keeping be considered the only criterion of exposure to cat/dog allergens in the first year of life? 446
Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma? 446
Umeclidinium for the treatment of chronic obstructive pulmonary disease 445
Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease 445
Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients 443
The prevalence of asthma and COPD in Italy: a practice-based study 441
Tiotropium formulations and safety: a network meta-analysis 441
Asthma and comorbid medical illness 435
Effects of chronic treatment with the new ultra-long-acting β2-adrenoceptor agonist indacaterol alone or in combination with the β1-adrenoceptor blocker metoprolol on cardiac remodelling 432
How many systemic reactions to skin prick tests could be preventable in defined conditions? 432
Is allergic sensitization to siberian hamster preventable in high-risk individuals who are already sensitized or exposed to furry animals? 431
Clinical effect of corticosteroids in asthma-affected horses: A quantitative synthesis 430
The Challenges of Precision Medicine in COPD 429
Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD 429
Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study 428
Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways 428
Is H1-antihistamine (desloratadine 5 mg, orodispersible tablet) premedication in NSAID-associated urticaria really safe and practicable in “real life”? 428
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD 427
The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils 426
New Treatments for COPD in the Elderly 423
Dog allergen immunotherapy and allergy to furry animals 423
The effect of indacaterol during an acute exacerbation of COPD 422
Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi 421
Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? 421
Translational study searching for synergy between glycopyrronium and indacaterol 419
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi 419
Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi 418
Comorbidities of asthma 415
The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease 415
Can the presence of cat/dog at home be considered the only criterion of exposure to cat/dog allergens? A likely underestimated bias in clinical practice and in large epidemiological studies 414
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study 414
Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008 413
Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi 413
Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity 412
Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi 412
Letter to the Editor: Can dog allergen immunotherapy reduce concomitant allergic sensitization to other furry animals? A preliminary experience 411
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis 408
Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone 405
The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle. 405
Brensocatib: Dipeptidyl peptidase 1 (DPP1) inhibitor Treatment of non-cystic fibrosis bronchiectasis 402
Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis 399
Is the risk of developing atopic sensitization and bronchial asthma in animal laboratory workers preventable in well-defined susceptible individuals? 397
What could the role of can f 5 allergen be in dog-sensitized patients in “real life”? 394
Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens 392
Critical aspects in dog allergen immunotherapy (DAI). May Component Resolved Diagnosis (CRD) play a role in predicting the efficacy? 392
Combining long-acting bronchodilators with different mechanisms of action: A pharmacological approach to optimize bronchodilation of equine airways 392
Chronic cat allergen exposure and low sensitization: Possible limitations in patient selection? 389
Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics 389
Gastroesophageal reflux and COPD exacerbations: Is cholinergic-mediated oesophago-bronchial reflex a possible link? 388
The clinical use of regenerative therapy in COPD 384
Partial nephrectomy using radiofrequency incremental bipolar generator with multi electrode probe: experimental study in bench pig kidneys 383
Partial renal resection by LaparoNewPro: in vivo open and laparoscopic study in an animal model 377
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: An Italian Multicenter Study 375
Diabetes mellitus among outpatients with COPD attending a university hospital. 374
Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine 374
Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways 372
Brain natriuretic peptide protects against hyperresponsiveness of human asthmatic airway smooth muscle via an epithelial cell-dependent mechanism 371
Relationship between oxytocin/vasopressin and latex in obstetric surgery: How to recognize (and prevent) allergic reactions and differentiate them from side effects? 369
Anaphylaxis and intimate behaviour 368
Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus 362
Contribution of sensory nerves to LPS-induced hyperresponsiveness of human isolated bronchi 361
Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue 361
Anxiety and asthma in youth. Is a stress-induced increased cholinergic tone the possible link? 358
Phosphodiesterase inhibitors for chronic obstructive pulmonary disease: what does the future hold? 356
Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis 355
Brain natriuretic peptide: Much more than a biomarker 354
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis 351
Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma 350
Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi 348
Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how 346
Canakinumab for the treatment of chronic obstructive pulmonary disease 333
Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi 326
Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008 322
Is ICS–LAMA an alternative option to treat patients with COPD? 317
Totale 41.817
Salva come PNG Salva come JPEG
Categoria #
all - tutte 159.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.499
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021663 0 0 0 0 0 0 0 0 0 239 315 109
2021/20221.892 126 173 30 31 54 186 218 76 115 203 182 498
2022/20232.109 264 148 60 236 167 537 205 126 199 14 91 62
2023/2024928 196 23 59 16 62 145 68 118 37 52 19 133
2024/20255.702 163 1.180 601 286 187 228 485 263 488 626 624 571
2025/20268.420 588 480 1.011 695 1.074 429 1.212 1.108 1.182 641 0 0
Totale 61.164